Steven Berman, MD
Interventional Pain Medicine · Reno, NVNPI 1720013055
Payments from drug & device makers
Across 654 payments — averaging $38.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$14K
- Abbott$2K
- AbbVie$686
- Boston Scientific$664
- Tersera Therapeutics LLC$623
- Saluda Medical Americas, Inc.$604
- plus $6K from 47 others
What the payments were for
- Speaking & faculty fees$8,84535%
- Travel & lodging$1,9038%
- Food & beverage$14,50657%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$6,287
- SYNCHROMEDII$3,824
- Proclaim Family of SCS IPGs$1,699
- SYNCHROMED$503
- INTELLIS$378
- SUPERION$267
- INCEPTIV$172
- StimQ Peripheral Nerve StimulatorSystem$134
- SCS FreedonSpinal Cord Stimulator$134
- SPRINT PNS System$132
- PRIALT$119
- mild Device Kit$117
- Qutenza$116
- Omnia$113
- RESTORE$112
How this compares
$25,254 in reported general payments places this provider in the 80th percentile of 32 interventional pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $9,440 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 12 | $9,099 |
| OxycontinOxycodone Hcl | 11 | $6,032 |
| Buprenorphine | 18 | $5,647 |
| Oxycodone Hcl | 126 | $2,610 |
| Gabapentin | 108 | $2,243 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 107 | $2,144 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 179 | $2,041 |
| Morphine Sulfate ErMorphine Sulfate | 46 | $1,199 |
| Buprenorphine Hcl | 24 | $846 |
| Pregabalin | 36 | $723 |
| Duloxetine Hcl | 32 | $497 |
| Tizanidine Hcl | 31 | $476 |
| Tramadol Hcl | 70 | $306 |
| Baclofen | 14 | $304 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Reno
- Ali NairiziReno$691K
- Benjamin GillReno$22K
- Christopher WoolleyReno$18K
- Michael FishellHenderson$325K
- Jeffrey KatzNorth Las Vegas$171K
- Daniel BurkheadLas Vegas$29K
- Adam AntflickLas Vegas$26K
- Stephen GephardtLas Vegas$14K
- Jeremy LipshutzLas Vegas$13K
- Denys GoloshchapovLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.